CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $420,000 | -18.1% | 30,099 | 0.0% | 0.06% | -25.9% |
| Q1 2017 | $513,000 | +65.5% | 30,099 | 0.0% | 0.08% | +37.3% |
| Q4 2016 | $310,000 | -99.9% | 30,099 | 0.0% | 0.06% | +22.9% |
| Q3 2016 | $304,301,000 | +89929.9% | 30,099 | 0.0% | 0.05% | -20.0% |
| Q2 2016 | $338,000 | – | 30,099 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,932,123 | $44,246,000 | 4.48% |
| Ghost Tree Capital, LLC | 350,000 | $8,015,000 | 1.62% |
| INGALLS & SNYDER LLC | 1,322,062 | $30,275,000 | 1.48% |
| SENZAR ASSET MANAGEMENT, LLC | 199,139 | $4,561,000 | 1.44% |
| Matarin Capital Management, LLC | 285,450 | $6,536,805,000 | 0.49% |
| KNOTT DAVID M | 49,557 | $1,135,000 | 0.47% |
| Spark Investment Management LLC | 144,600 | $3,311,000 | 0.21% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $380,000 | 0.17% |
| TIVERTON ASSET MANAGEMENT LLC | 77,782 | $1,781,000 | 0.12% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,240 | $1,883,000 | 0.12% |